EUVIMEDEUVIMED entdecken
Crossref

Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr.etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflammasome-mediated pyroptosis via NLRP3/caspase-1 pathway

Nan Jia, Zherui Shen, Sijing Zhao, Yilan Wang, Caixia Pei, Demei Huang, Xiaomin Wang, Yongcan Wu, Shihua Shi, Yacong He, Zhenxing Wang

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Nan Jia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, China. Hauptthemen laut MEDLINE: Eleutherococcus, Heart Injuries. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: Sichuan Provincial Administration of Traditional Chinese Medicine, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eleutheroside E, a major natural bioactive compound in Acanthopanax senticosus (Rupr.etMaxim.) Harms, possesses anti-oxidative, anti-fatigue, anti-inflammatory, anti-bacterial and immunoregulatory effects. High-altitude hypobaric hypoxia affects blood flow and oxygen utilisation, resulting in severe heart injury that cannot be reversed, thereby eventually causing or exacerbating high-altitude heart disease and heart failure. The purpose of this study was to determine the cardioprotective effects of eleutheroside E against high-altitude-induced heart injury (HAHI), and to study the mechanisms by which this happens. A hypobaric hypoxia chamber was used in the study to simulate hypobaric hypoxia at the high altitude of 6000 m. 42 male rats were randomly assigned to 6 equal groups and pre-treated with saline, eleutheroside E 100 mg/kg, eleutheroside E 50 mg/kg, or nigericin 4 mg/kg. Eleutheroside E exhibited significant dose-dependent effects on a rat model of HAHI by suppressing inflammation and pyroptosis. Eleutheroside E downregulated the expressions of brain natriuretic peptide (BNP), creatine kinase isoenzymes (CK-MB) and lactic dehydrogenase (LDH). Moreover, The ECG also showed eleutheroside E improved the changes in QT interval, corrected QT interval, QRS interval and heart rate. Eleutheroside E remarkably suppressed the expressions of NLRP3/caspase-1-related proteins and pro-inflammatory factors in heart tissue of the model rats. Nigericin, known as an agonist of NLRP3 inflammasome-mediated pyroptosis, reversed the effects of eleutheroside E. Eleutheroside E prevented HAHI and inhibited inflammation and pyroptosis via the NLRP3/caspase-1 signalling pathway. Taken together, eleutheroside E is a prospective, effective, safe and inexpensive agent that can be used to treat HAHI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EleutherococcusHeart InjuriesMaleRatsAnimalsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisCaspase 1AltitudeNigericinProspective StudiesAnti-Inflammatory AgentsInflammationHypoxiaGlucosidesLignans

Stichwörter der Autor:innen

Anti-inflammationAnti-pyroptosisEleutheroside EHigh-altitude-induced heart injury (HAHI)

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinCaspase 1NigericinAnti-Inflammatory Agentseleutheroside EGlucosidesLignans

Autor:innen und Institutionen

  • Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, China.
  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, China. Electronic address: heyacong@cdutcm.edu.cn.
  • Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, China. Electronic address: wangzhenxing@cdutcm.edu.cn.

Förderung

  • Sichuan Provincial Administration of Traditional Chinese Medicine
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Jia, N., Shen, Z., Zhao, S., Wang, Y., Pei, C., Huang, D., Wang, X., Wu, Y., Shi, S., He, Y., & Wang, Z. (2023). Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr.etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflammasome-mediated pyroptosis via NLRP3/caspase-1 pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110423

Vancouver

Jia N, Shen Z, Zhao S, Wang Y, Pei C, Huang D, et al. Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr.etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflammasome-mediated pyroptosis via NLRP3/caspase-1 pathway. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110423

BibTeX
@article{Jia2023,
  author = {Jia, Nan and Shen, Zherui and Zhao, Sijing and Wang, Yilan and Pei, Caixia and Huang, Demei and Wang, Xiaomin and Wu, Yongcan and Shi, Shihua and He, Yacong and Wang, Zhenxing},
  title = {Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr.etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflammasome-mediated pyroptosis via NLRP3/caspase-1 pathway},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110423}
}
Kostenlos starten →